Modius Sleep

About Neurovalens

Neurovalens, founded in 2014 in Belfast, is a commercial-stage medical device company focused on non-invasive neurostimulation. Its core technology platform uses electrical vestibular nerve stimulation (VeNS) to modulate brain activity, with its first FDA-cleared product, Modius Sleep, targeting chronic insomnia. The company has secured regulatory approvals in the US, UK, and EU, is expanding its pipeline into weight management, and has raised significant venture funding to support growth. Neurovalens positions itself as a digital health leader offering alternatives to pharmaceuticals for neurological and metabolic conditions.

Therapeutic Areas